• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Plasma somatostatin response to an oral mixed test meal in cirrhotic patients.

作者信息

Barreca T, Franceschini R, Cataldi A, Rolandi E

机构信息

Department of Internal Medicine, University of Genoa, Italy.

出版信息

J Hepatol. 1991 Jan;12(1):40-4. doi: 10.1016/0168-8278(91)90906-r.

DOI:10.1016/0168-8278(91)90906-r
PMID:1672540
Abstract

Ten patients with non-alcoholic cirrhosis and ten control subjects were studied in basal conditions and after ingestion of a standard mixed test meal. Plasma somatostatin, blood glucose, plasma insulin, C-peptide and glucagon were determined before and 15, 30, 45, 60, 90, 120 and 180 min after the start of the meal. Basal somatostatin levels in patients (31.9 +/- 1.8 ng/l) were significantly higher (p less than 0.01) than in controls (12.5 +/- 0.9 ng/l). The time-course of the somatostatin secretory response after the meal was similar in the two groups, but the increase, evaluated as incremental area above baseline, was significantly smaller (p less than 0.01) in cirrhotics (804 +/- 134 ng/l per min) than in controls (1482 +/- 149 ng/l per min). Data indicate that elevated basal plasma somatostatin concentrations in cirrhosis may be consequent to elevated gastrointestinal and/or pancreatic secretion, whereas the blunted somatostatin response to the mixed test meal may derive from the hyperinsulinemia which occurs in the postprandial period.

摘要

相似文献

1
Plasma somatostatin response to an oral mixed test meal in cirrhotic patients.
J Hepatol. 1991 Jan;12(1):40-4. doi: 10.1016/0168-8278(91)90906-r.
2
Circulating somatostatin concentrations in healthy and cirrhotic subjects.健康受试者和肝硬化受试者的循环生长抑素浓度。
Metabolism. 1986 Feb;35(2):130-5. doi: 10.1016/0026-0495(86)90113-7.
3
Plasma somatostatin response to an oral test meal in liver transplant patients.肝移植患者口服试验餐时血浆生长抑素的反应。
Metabolism. 1997 Sep;46(9):1003-7. doi: 10.1016/s0026-0495(97)90269-9.
4
Plasma somatostatin and vasoactive intestinal polypeptide responses to an oral mixed test meal in obese patients.肥胖患者口服混合试验餐时血浆生长抑素和血管活性肠肽的反应。
Horm Res. 1989;31(5-6):234-7. doi: 10.1159/000181123.
5
Glucose intolerance in thyrotoxicosis roles of insulin, glucagon and somatostatin.甲状腺毒症中葡萄糖不耐受:胰岛素、胰高血糖素和生长抑素的作用
Acta Endocrinol (Copenh). 1987 Feb;114(2):228-34. doi: 10.1530/acta.0.1140228.
6
Effects of insulin on fasting and meal-stimulated somatostatin-like immunoreactivity in noninsulin-dependent diabetes mellitus: evidence for more than one mechanism of action.胰岛素对非胰岛素依赖型糖尿病患者空腹及进餐刺激下生长抑素样免疫反应性的影响:多种作用机制的证据
J Clin Endocrinol Metab. 1986 Jan;62(1):77-83. doi: 10.1210/jcem-62-1-77.
7
Pancreatic beta-cell function in cirrhotic patients with and without overt diabetes. C-peptide response to glucagon and to meal.患有和未患显性糖尿病的肝硬化患者的胰腺β细胞功能。C肽对胰高血糖素和进食的反应。
Metabolism. 1985 Aug;34(8):695-701. doi: 10.1016/0026-0495(85)90017-4.
8
Effect of low-dose somatostatin infusion on pancreatic and gastric endocrine function in lean and obese nondiabetic human subjects.低剂量生长抑素输注对瘦型和肥胖型非糖尿病人体胰腺和胃内分泌功能的影响。
Diabetes. 1985 Jun;34(6):595-601. doi: 10.2337/diab.34.6.595.
9
Somatostatin release in response to glucose is impaired in chronic renal failure.在慢性肾衰竭中,对葡萄糖作出反应的生长抑素释放受损。
Biomed Pharmacother. 1998;52(5):208-13. doi: 10.1016/S0753-3322(98)80018-8.
10
Glucagon and glucose tolerance in liver cirrhosis.肝硬化患者的胰高血糖素与葡萄糖耐量
Acta Endocrinol (Copenh). 1988 Jul;118(3):337-45. doi: 10.1530/acta.0.1180337.

引用本文的文献

1
Frequency and Causes of False-Positive Elevated Plasma Concentrations of Fasting Gut Hormones in a Specialist Neuroendocrine Tumor Center.在一家神经内分泌肿瘤专科中心,空腹肠激素血浓度升高的假阳性频率和原因。
Front Endocrinol (Lausanne). 2020 Dec 16;11:606264. doi: 10.3389/fendo.2020.606264. eCollection 2020.
2
Gallstones in Patients with Chronic Liver Diseases.慢性肝病患者的胆结石
Biomed Res Int. 2017;2017:9749802. doi: 10.1155/2017/9749802. Epub 2017 Jan 31.
3
Gallstones in patients with liver cirrhosis: incidence, etiology, clinical and therapeutical aspects.
肝硬化患者的胆结石:发病率、病因、临床及治疗方面
World J Gastroenterol. 2014 Jun 21;20(23):7277-85. doi: 10.3748/wjg.v20.i23.7277.
4
Gallbladder contractility in liver cirrhosis: comparative study in patients with and without gallbladder stones.肝硬化患者的胆囊收缩功能:有胆囊结石与无胆囊结石患者的对比研究
Dig Dis Sci. 2004 Jan;49(1):17-24. doi: 10.1023/b:ddas.0000011596.33237.5c.
5
Gallbladder emptying, plasma levels of estradiol and progesterone, and cholecystokinin secretion in liver cirrhosis.肝硬化患者的胆囊排空、雌二醇和孕酮的血浆水平以及胆囊收缩素分泌
Dig Dis Sci. 1995 Feb;40(2):428-34. doi: 10.1007/BF02065433.
6
An experimental study on somatostatin receptors in the brains of hepatic encephalopathy rats.
J Tongji Med Univ. 1994;14(3):129-32. doi: 10.1007/BF02886791.